CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 177 filers reported holding CARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2021 | $21,392,000 | -61.3% | 1,499,058 | -41.2% | 1.96% | -63.2% |
| Q1 2021 | $55,340,000 | +30.7% | 2,549,058 | -8.9% | 5.32% | -76.1% |
| Q4 2020 | $42,350,000 | +18.9% | 2,799,058 | 0.0% | 22.29% | -24.8% |
| Q3 2020 | $35,618,000 | -25.6% | 2,799,058 | 0.0% | 29.66% | -4.3% |
| Q2 2020 | $47,864,000 | +13.5% | 2,799,058 | -12.3% | 31.00% | -27.1% |
| Q1 2020 | $42,180,000 | -18.0% | 3,193,057 | 0.0% | 42.50% | +8.7% |
| Q4 2019 | $51,440,000 | -11.9% | 3,193,057 | 0.0% | 39.10% | -20.0% |
| Q3 2019 | $58,369,000 | -16.9% | 3,193,057 | -2.3% | 48.88% | +0.3% |
| Q2 2019 | $70,263,000 | +0.4% | 3,268,057 | -8.4% | 48.74% | -34.2% |
| Q1 2019 | $70,005,000 | +50.9% | 3,568,057 | 0.0% | 74.08% | +8.8% |
| Q4 2018 | $46,385,000 | -45.7% | 3,568,057 | 0.0% | 68.07% | -13.4% |
| Q3 2018 | $85,455,000 | +25.1% | 3,568,057 | 0.0% | 78.61% | +20.3% |
| Q2 2018 | $68,328,000 | +54.7% | 3,568,057 | 0.0% | 65.36% | +4.9% |
| Q1 2018 | $44,173,000 | +1.1% | 3,568,057 | 0.0% | 62.30% | -17.9% |
| Q4 2017 | $43,673,000 | -10.6% | 3,568,057 | 0.0% | 75.90% | -1.3% |
| Q3 2017 | $48,847,000 | -11.0% | 3,568,057 | 0.0% | 76.92% | +0.3% |
| Q2 2017 | $54,912,000 | -16.3% | 3,568,057 | 0.0% | 76.67% | -16.9% |
| Q1 2017 | $65,617,000 | +130.2% | 3,568,057 | +16.3% | 92.21% | +322.3% |
| Q4 2016 | $28,502,000 | +11.3% | 3,068,057 | 0.0% | 21.84% | +26.2% |
| Q3 2016 | $25,618,000 | +73.6% | 3,068,057 | 0.0% | 17.30% | +46.6% |
| Q2 2016 | $14,757,000 | -22.7% | 3,068,057 | 0.0% | 11.80% | +13.0% |
| Q1 2016 | $19,083,000 | -57.6% | 3,068,057 | +15.0% | 10.45% | -32.4% |
| Q4 2015 | $44,983,000 | +18.0% | 2,668,057 | 0.0% | 15.47% | +22.1% |
| Q3 2015 | $38,127,000 | +17.6% | 2,668,057 | 0.0% | 12.66% | +11.7% |
| Q2 2015 | $32,417,000 | +20.9% | 2,668,057 | 0.0% | 11.34% | +1.4% |
| Q1 2015 | $26,814,000 | +0.8% | 2,668,057 | 0.0% | 11.18% | -5.3% |
| Q4 2014 | $26,601,000 | +18.8% | 2,668,057 | 0.0% | 11.80% | +5.0% |
| Q3 2014 | $22,385,000 | -50.7% | 2,668,057 | 0.0% | 11.24% | -36.3% |
| Q2 2014 | $45,410,000 | -8.5% | 2,668,057 | 0.0% | 17.64% | -9.0% |
| Q1 2014 | $49,653,000 | – | 2,668,057 | – | 19.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |